Thyroid Eye Disease: Clinical Trials

2 trials for Thyroid Eye Disease, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 active not recruiting. 2 Phase 1, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 12Active not recruiting 2
Phase 21Active not recruiting 1

Follow Thyroid Eye Disease: new trials by email Literature Review of Thyroid Eye Disease trials Research Report on Thyroid Eye Disease

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Trial Investigating Lu AG22515 in Adult Participants With Moderate-to-Severe Thyroid Eye Disease
Lu AG22515 - Thyroid Eye Disease
Phase 1Active not recruitingH. Lundbeck A/S202024-09-192026-09-09
A Study of AMG 732 in Healthy Participants and Participants With Thyroid Eye Disease
AMG 732, Placebo - Thyroid Eye Disease
Phase 1 / Phase 2Active not recruitingAmgen942024-05-302026-08-10

Narrower conditions

Graves Ophthalmopathy (2)

Broader conditions

Autoimmune Diseases (2)  ·  Congenital, Hereditary, and Neonatal Diseases and Abnormalities (2)  ·  Endocrine System Diseases (2)  ·  Exophthalmos (2)  ·  Eye Diseases (2)  ·  Eye Diseases, Hereditary (2)  ·  Genetic Diseases, Inborn (2)  ·  Goiter (2)  ·  Graves Disease (2)  ·  Hyperthyroidism (2)  ·  Immune System Diseases (2)  ·  Orbital Diseases (2)  ·  Thyroid Diseases (2)

Sponsors

Amgen (1)  ·  H. Lundbeck A/S (1)

Countries

Poland (2)  ·  Australia (1)  ·  Bosnia and Herzegovina (1)  ·  Bulgaria (1)  ·  Canada (1)  ·  France (1)  ·  Germany (1)  ·  Greece (1)  ·  Italy (1)  ·  Japan (1)  ·  Singapore (1)  ·  Spain (1)  ·  Taiwan (1)  ·  United States (1)

NIH funding

2023 (1)